ANGO NASDAQ
AngioDynamics, Inc.
1W: +8.4%
1M: +7.5%
3M: +6.6%
YTD: -5.7%
1Y: +25.8%
3Y: +26.8%
5Y: -47.9%
$11.92
-0.04 (-0.33%)
Weekly Expected Move ±4.1%
$10
$10
$11
$11
$12
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
2 bullish
0 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (59)
Wall Street Analysts See a 50.5% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High?
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet
FY2026 EPS Estimates for AngioDynamics Increased by Analyst
Q3 EPS Estimates for AngioDynamics Lowered by Zacks Research
AngioDynamics, Inc. (NASDAQ:ANGO) Given Consensus Recommendation of “Moderate Buy” by Analysts
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 65.75%: Here's is How to Trade
JPMorgan Chase & Co. Sells 55,503 Shares of AngioDynamics, Inc. $ANGO
AngioDynamics (ANGO) Loses 5.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
HC Wainwright Predicts Increased Earnings for AngioDynamics
AngioDynamics (ANGO) Upgraded to Buy: Here's Why
Q3 EPS Estimates for AngioDynamics Lifted by HC Wainwright
ANGO Stock Up in Pre-Market Post Q3 Earnings Beat, Gross Margin Down
AngioDynamics signals FY2026 adjusted EBITDA of $10M-$12M while raising net sales guidance to $313.5M-$315.5M
AngioDynamics (ANGO) Reports Q3 Loss, Tops Revenue Estimates
Earnings Scheduled For April 2, 2026
AngioDynamics Non-GAAP EPS of -$0.07 beats by $0.04, revenue of $78.42M beats by $1.65M
Nasdaq Gains Over 1% On War De-Escalation Hopes: Investor Fear Eases, But Fear & Greed Index Remains In 'Extreme Fear' Zone
Acuity, Lindsay And 3 Stocks To Watch Heading Into Thursday
Here are the major earnings before the open Thursday
AngioDynamics, Inc. $ANGO Shares Sold by Assenagon Asset Management S.A.
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0%
Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lag
Earnings week ahead: NKE, TLRY, SPCE, BYND, NNDM, CAG, and more
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Average Recommendation of “Moderate Buy” from Brokerages
InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates
Acuitas Investments LLC Buys 56,300 Shares of AngioDynamics, Inc. $ANGO
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates
RGTI Stock Down Despite Q4 Earnings Top Estimates, Revenues Decline Y/Y
AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Rating of “Moderate Buy” by Analysts
Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect?
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now
Acuitas Investments LLC Has $5.57 Million Stake in AngioDynamics, Inc. $ANGO
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)
ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves
AngioDynamics Q2 Earnings Call Highlights
Why AngioDynamics Stock Is Sinking Today
AngioDynamics, Inc. (ANGO) Q2 2026 Earnings Call Transcript
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability
AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
AngioDynamics (NASDAQ:ANGO) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?
AngioDynamics: Growth Remains Under The Radar
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026
AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Delcath Systems (NASDAQ:DCTH) vs. AngioDynamics (NASDAQ:ANGO) Head-To-Head Survey
AXQ Capital LP Has $270,000 Holdings in AngioDynamics, Inc. $ANGO
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now